|
Volumn 47, Issue 6, 2013, Pages 553-558
|
Drug-induced liver injury caused by intravenously administered medications: The drug-induced liver injury network experience
|
Author keywords
DILIN; Drug induced liver injury; Hepatotoxicity; Intravenous
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ALKALINE PHOSPHATASE;
ASPARAGINASE;
BILIRUBIN;
BORTEZOMIB;
CARBOPLATIN;
CARDIOVASCULAR AGENT;
CEFAZOLIN;
CEFTRIAXONE;
CEPHALOSPORIN DERIVATIVE;
CIPROFLOXACIN;
CLINDAMYCIN;
COTRIMOXAZOLE;
DOCETAXEL;
IMMUNOMODULATING AGENT;
INFLIXIMAB;
INTERLEUKIN 21;
LEVOFLOXACIN;
MACROLIDE;
METOPROLOL;
MOXIFLOXACIN;
OCTREOTIDE;
OXACILLIN;
PENICILLIN DERIVATIVE;
PHENYTOIN;
PIPERACILLIN PLUS TAZOBACTAM;
QUINOLONE DERIVATIVE;
RIFAMPICIN;
SULFONAMIDE;
THYMOCYTE ANTIBODY;
ADULT;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
ALKALINE PHOSPHATASE BLOOD LEVEL;
ARTICLE;
BILIRUBIN BLOOD LEVEL;
CHOLESTATIC HEPATITIS;
CLINICAL ARTICLE;
CLINICAL FEATURE;
FEMALE;
HUMAN;
MALE;
PRIORITY JOURNAL;
TOXIC HEPATITIS;
DRUG-INDUCED LIVER INJURY;
FEMALE;
HUMANS;
INFUSIONS, INTRAVENOUS;
MALE;
MIDDLE AGED;
PROSPECTIVE STUDIES;
|
EID: 84879882827
PISSN: 01920790
EISSN: 15392031
Source Type: Journal
DOI: 10.1097/MCG.0b013e318276bf00 Document Type: Article |
Times cited : (20)
|
References (9)
|